相关实验视频

Updated: Jan 9, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

一个令人惊的联系:TET2 克隆造血增强了免疫检查点疗法

Qiang Dong¹, Chengcheng Jin¹

¹Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

|December 10, 2025

概括

四肢性2 (TET2) 突变驱动克隆血液形成,重编程与瘤相关的巨细胞. 这种重编程增强了抗原呈现,并提高了固体瘤的免疫检查点疗法的有效性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

四肢2 (TET2) 突变是已知的克隆性血液形成 (CH) 的驱动因素.
TET2突变CH对瘤微环境和免疫反应的影响尚未完全理解.
了解这种相互作用对于开发新型癌症免疫疗法至关重要.

研究的目的:

为了研究TET2突变克隆性血液形成对瘤免疫力的影响.
探索TET2突变影响瘤相关巨细胞 (TAMs) 的机制.
确定这些变化对固体瘤进展和免疫治疗反应的影响.

主要方法:

对患者数据和具有TET2突变的小鼠模型的分析.
流细胞计和单细胞RNA测序用于特征TAMs.
在体内和体外测试以评估抗原呈现和T细胞反应.
在相关模型中评估免疫检查点阻塞疗法的疗效.

主要成果:

发现TET2突变CH可以在瘤微环境中重编程TAM.
重编程的TAM表现出MHCII类分子的增强表达,改善了抗原呈现.
这种TAM重编程导致了抗瘤T细胞反应的改善,并提高了固体瘤免疫检查点治疗的疗效.

结论:

在CH中TET2突变可以调节实体瘤的免疫格局.
由TET2突变CH重编程TAMs代表了一种增强抗瘤免疫力的新机制.
向TET2突变CH相关的TAM可能提供一种治疗策略,以改善免疫治疗结果.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...